Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 1
2001 2
2002 2
2003 1
2004 1
2005 2
2006 3
2007 4
2008 2
2009 9
2010 2
2011 4
2012 3
2013 6
2014 8
2015 10
2016 9
2017 8
2018 7
2019 7
2020 3
2021 9
2022 3
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

91 results

Results by year

Filters applied: . Clear all
Page 1
Polyclonal hypergammaglobulinaemia: assessment, clinical interpretation, and management.
Zhao EJ, Cheng CV, Mattman A, Chen LYC. Zhao EJ, et al. Lancet Haematol. 2021 May;8(5):e365-e375. doi: 10.1016/S2352-3026(21)00056-9. Lancet Haematol. 2021. PMID: 33894171 Review.
Polyclonal hypergammaglobulinaemia is most commonly caused by liver disease, immune dysregulation, or inflammation, but can also provide an important diagnostic clue of rare diseases such as histiocyte disorders, autoimmune lymphoproliferative syndrome, Castl …
Polyclonal hypergammaglobulinaemia is most commonly caused by liver disease, immune dysregulation, or inflammation, but can also provide an …
Autoimmune and medication-induced lymphadenopathies.
Gru AA, O'Malley DP. Gru AA, et al. Semin Diagn Pathol. 2018 Jan;35(1):34-43. doi: 10.1053/j.semdp.2017.11.015. Epub 2017 Nov 28. Semin Diagn Pathol. 2018. PMID: 29208331 Review.
Some of these disorders are more characteristic of individuals in the pediatric age group (autoimmune lymphoproliferative syndrome, Kawasaki disease), while others present in older individuals (rheumatoid arthritis, lupus erythematosus, sarcoidosis). ...
Some of these disorders are more characteristic of individuals in the pediatric age group (autoimmune lymphoproliferative s …
Autoimmune lymphoproliferative syndrome: an update and review of the literature.
Shah S, Wu E, Rao VK, Tarrant TK. Shah S, et al. Curr Allergy Asthma Rep. 2014 Sep;14(9):462. doi: 10.1007/s11882-014-0462-4. Curr Allergy Asthma Rep. 2014. PMID: 25086580 Free PMC article. Review.
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by immune dysregulation due to a defect in lymphocyte apoptosis. The clinical manifestations may be noted in multiple family members and include lymphadenopathy, splenomegaly, increased ri …
Autoimmune lymphoproliferative syndrome (ALPS) is characterized by immune dysregulation due to a defect in lymphocyte a …
Optimal Management of Autoimmune Lymphoproliferative Syndrome in Children.
George LA, Teachey DT. George LA, et al. Paediatr Drugs. 2016 Aug;18(4):261-72. doi: 10.1007/s40272-016-0175-3. Paediatr Drugs. 2016. PMID: 27139496 Free PMC article. Review.
Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of abnormal lymphocyte homeostasis, resulting from mutations in the Fas apoptotic pathway. Clinical manifestations include noninfectious and nonmalignant lymphadenopathy, splenomegaly, and au …
Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of abnormal lymphocyte homeostasis, resulting from mutatio …
Autoimmune lymphoproliferative syndrome: A disorder of immune dysregulation.
Paskiewicz A, Niu J, Chang C. Paskiewicz A, et al. Autoimmun Rev. 2023 Nov;22(11):103442. doi: 10.1016/j.autrev.2023.103442. Epub 2023 Sep 6. Autoimmun Rev. 2023. PMID: 37683818 Review.
Autoimmune Lymphoproliferative Syndrome (ALPS) is an autoimmune disease that has been reported in over 2200 patients. ...
Autoimmune Lymphoproliferative Syndrome (ALPS) is an autoimmune disease that has been reported in over 2200 patients. . …
An Update on the Use of Immunomodulators in Primary Immunodeficiencies.
Vignesh P, Rawat A, Singh S. Vignesh P, et al. Clin Rev Allergy Immunol. 2017 Apr;52(2):287-303. doi: 10.1007/s12016-016-8591-2. Clin Rev Allergy Immunol. 2017. PMID: 27873163 Review.
These agents have been shown conclusively to favorably modulate immune responses, resulting in abatement of clinical manifestations both in experimental models and patients. While some of the treatment options have been approved for therapeutic use or have been shown to be …
These agents have been shown conclusively to favorably modulate immune responses, resulting in abatement of clinical manifestations b …
Autoimmune Cytopenias and Dysregulated Immunophenotype Act as Warning Signs of Inborn Errors of Immunity: Results From a Prospective Study.
Schiavo E, Martini B, Attardi E, Consonni F, Ciullini Mannurita S, Coniglio ML, Tellini M, Chiocca E, Fotzi I, Luti L, D'Alba I, Veltroni M, Favre C, Gambineri E. Schiavo E, et al. Front Immunol. 2022 Jan 4;12:790455. doi: 10.3389/fimmu.2021.790455. eCollection 2021. Front Immunol. 2022. PMID: 35058929 Free PMC article. Clinical Trial.
Inborn errors of immunity (IEI) are genetic disorders characterized by a wide spectrum of clinical manifestations, ranging from increased susceptibility to infections to significant immune dysregulation. ...Key IEI-associated alterations causative of STAT3 GOF disease, IKA …
Inborn errors of immunity (IEI) are genetic disorders characterized by a wide spectrum of clinical manifestations, ranging from incre …
Diagnosis and management of autoimmune cytopenias in childhood.
Teachey DT, Lambert MP. Teachey DT, et al. Pediatr Clin North Am. 2013 Dec;60(6):1489-511. doi: 10.1016/j.pcl.2013.08.009. Epub 2013 Oct 5. Pediatr Clin North Am. 2013. PMID: 24237984 Free PMC article. Review.
This nonspecific approach is changing as recent insights into disease biology have led to targeted therapies, including the use of thrombopoietin mimetics in ITP and sirolimus for cytopenias associated with autoimmune lymphoproliferative syndrome....
This nonspecific approach is changing as recent insights into disease biology have led to targeted therapies, including the use of thrombopo …
New advances in the diagnosis and treatment of autoimmune lymphoproliferative syndrome.
Teachey DT. Teachey DT. Curr Opin Pediatr. 2012 Feb;24(1):1-8. doi: 10.1097/MOP.0b013e32834ea739. Curr Opin Pediatr. 2012. PMID: 22157362 Free PMC article. Review.
PURPOSE OF REVIEW: Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of disrupted lymphocyte homeostasis, resulting from mutations in the Fas apoptotic pathway. Clinical manifestations include lymphadenopathy, splenomegaly, and autoimmune cy …
PURPOSE OF REVIEW: Autoimmune lymphoproliferative syndrome (ALPS) is a disorder of disrupted lymphocyte homeostasis, re …
How I manage Evans Syndrome and AIHA cases in children.
Miano M. Miano M. Br J Haematol. 2016 Feb;172(4):524-34. doi: 10.1111/bjh.13866. Epub 2015 Dec 2. Br J Haematol. 2016. PMID: 26625877 Free article. Review.
For children who are resistant, relapse or become steroid-dependent, rituximab is considered a valid second-line treatment, with the exception of those with an underlying diagnosis of autoimmune lymphoproliferative syndrome who may benefit from other options …
For children who are resistant, relapse or become steroid-dependent, rituximab is considered a valid second-line treatment, with the excepti …
91 results